CVS vs MDT: Which Stock Is the Better Buy?
CVS Health Corporation and Medtronic plc side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — CVS vs MDT, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| CVS Health Corporation (CVS) | Medtronic plc (MDT) | |
|---|---|---|
| Market cap | $133.6B | $106.5B |
| Revenue (latest FY) | $402.07B | $36.33B |
| Net income (latest FY) | $1.77B | $4.80B |
| Revenue growth (5y CAGR) | 8.4% | 3.8% |
| Net margin | 0.4% | 13.2% |
| Return on equity | 2.4% | 9.7% |
| P/E ratio | 45.9 | 22.3 |
| Dividend yield | 2.5% | 3.5% |
| Profitable years (of last 10) | 9 | 10 |
| Positive free cash flow | Yes | Yes |
See the full CVS vs MDT breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open CVS's full financials → Open MDT's full financials →Frequently asked questions
Which is bigger, CVS or MDT?
CVS Health Corporation is larger by market capitalization — $133.6B versus $106.5B.
Which grows faster, CVS or MDT?
Over the last five fiscal years, CVS Health Corporation grew revenue faster — 8.4%/yr versus 3.8%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.
Keep exploring
CVS fundamentals → · MDT fundamentals → · All 1,500+ companies → · Free screener →